New drug combo targets aggressive bone cancer in teens and young adults
Disease control
Completed
This study tested an experimental drug called TK216, given with the chemotherapy drug vincristine, for people aged 14 and older with Ewing's sarcoma that has come back or stopped responding to other treatments. The main goal was to see if this combination could shrink tumors and …
Phase: PHASE2 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC